Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Avatrombopag”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Post-approval studies (Phase 4)UnknownNCT04915287
What this trial is testing

Efficacy of Avatrombopag in Thrombocytopenic Patients With Chronic Liver Disease Undergoing an Elective Procedure

Who this might be right for
Thrombocytopenia; DrugsChronic Liver Disease
Chinese PLA General Hospital 476
Not applicableUnknownNCT05433922
What this trial is testing

Efficacy and Safety of CSA and Avatrombopag for the Treatment of SAA in the Elderly

Who this might be right for
Severe Aplastic Anemia
Institute of Hematology & Blood Diseases Hospital, China 80
Testing effectiveness (Phase 2)UnknownNCT06001567
What this trial is testing

Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC

Who this might be right for
ThrombocytopeniaHepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical University 30
Testing effectiveness (Phase 2)UnknownNCT05720234
What this trial is testing

Avatrombopag Combined With IST as First-line Treatment for SAA

Who this might be right for
Severe Aplastic Anemia
Institute of Hematology & Blood Diseases Hospital, China 53
Testing effectiveness (Phase 2)Study completedNCT00914927
What this trial is testing

Once-Daily Oral Avatrombopag Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures

Who this might be right for
Thrombocytopenia Related to Chronic Liver Disease
Eisai Inc. 130
Post-approval studies (Phase 4)UnknownNCT04906083
What this trial is testing

Avatrombopag in Patients With End-stage Liver Disease and Thrombocytopenia

Who this might be right for
Liver FailureThrombocytopeniaDecompensated Cirrhosis
Tongji Hospital 150
Testing effectiveness (Phase 2)WithdrawnNCT04437953
What this trial is testing

Avatrombopag for Thrombocytopenia in People With Cancer

Who this might be right for
ThrombocytopeniaCancerLiver Diseases
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)WithdrawnNCT05046327
What this trial is testing

Open-Label Study to Evaluate the Safety and Efficacy of Avatrombopag and Remission Rates in Adults With ITP of ≤6 Months

Who this might be right for
Immune Thrombocytopenia
Sobi, Inc.
Not applicableStudy completedNCT07600905
What this trial is testing

Avatrombopag for Severe Thrombocytopenia After Liver Transplantation: A Retrospective Cohort Study

Who this might be right for
Liver TransplanatationPostoperative ComplicationSevere Thrombocytopenia
Shanghai Zhongshan Hospital 134
Testing effectiveness (Phase 2)Looking for participantsNCT04993885
What this trial is testing

Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

Who this might be right for
Immune ThrombocytopeniaAutoantibodiesEvan Syndrome+1 more
Institute of Hematology & Blood Diseases Hospital, China 52
Large-scale testing (Phase 3)Not Yet RecruitingNCT07051915
What this trial is testing

The Holistic Study

Who this might be right for
Thrombocytopenia Purpura
Ostfold Hospital Trust 220
Large-scale testing (Phase 3)Study completedNCT04516967
What this trial is testing

Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months

Who this might be right for
Immune Thrombocytopenia
Sobi, Inc. 75
Not applicableUnknownNCT04949009
What this trial is testing

Avatrombopag in the Treatment of Primary Immune Thrombocytopenia(ITP)

Who this might be right for
Primary Immune Thrombocytopenia
Shandong University 400
Large-scale testing (Phase 3)Study completedNCT01976104
What this trial is testing

Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure

Who this might be right for
Thrombocytopenia Associated With Liver Disease
Eisai Inc. 204
Not applicableUnknownNCT05571332
What this trial is testing

Efficacy and Safety of Avatrombopag Combined With IST for the Treatment of HAAA and SAA With Abnormal Liver Function

Who this might be right for
Aplastic Anemia
Institute of Hematology & Blood Diseases Hospital, China 39
Not applicableUnknownNCT04913597
What this trial is testing

Switching Avatrombopag and Rh-TPO in ITP

Who this might be right for
Corticosteroid-resistant or Relapsed ITP
Peking University People's Hospital 100
Testing effectiveness (Phase 2)UnknownNCT06254287
What this trial is testing

Efficacy and Safety of Avatrombopag vs. Avatrombopag Combined With rhTPO in the Treatment of SAA

Who this might be right for
Anemia, Aplastic
Institute of Hematology & Blood Diseases Hospital, China 60
Large-scale testing (Phase 3)Study completedNCT01972529
What this trial is testing

Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure

Who this might be right for
Thrombocytopenia Associated With Liver Disease
Eisai Inc. 231
Large-scale testing (Phase 3)UnknownNCT04728789
What this trial is testing

Avatrombopag Usage in NSAA

Who this might be right for
Aplastic AnemiaDrug Effect
Peking Union Medical College Hospital 40
Large-scale testing (Phase 3)Looking for participantsNCT06202625
What this trial is testing

Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCT

Who this might be right for
ThrombocytopeniaStem Cell Transplant Complications
Peking University People's Hospital 142
Next Page